// App-Quantinova.ai

: Results from a phase I/Ib trial of enzalutamide and gemcitabine and cisplatin in metastatic bladder cancer (mBC).

Researchers

Presenter

  • Shilpa Gupta

Principal Investigators

  • Jasreman Dhillon

  • Anthony Martin Magliocco

  • John Puskas

  • Gisela Caceres

  • Fadzai Masawi

  • Yulia Doronin

  • Jingsong Zhang

Medical Centers

  • University of Minnesota Masonic Cancer Research Center, Minneapolis, MN

  • Anatomic Pathology, Moffitt Cancer Center, Tampa, FL

  • H. Lee Moffitt Cancer Center & Research Institute, Riverview, FL

  • Moffitt Cancer Center, Tampa, FL

  • H. Lee Moffitt Cancer Center & Research Institute, Riverview, FL

  • University of Minnesota, Minneapolis, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Enzalutamide

  • Gemcitabine

  • Cisplatin

Outcome

  • N/A

Study Design

  • Dose Escalation

  • Cohort

Phase

  • NA

Study Id's

  • NCT02300610

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved